Past News Releases

Researchmoz presents this most up-to-date research on Analysis of Global Biochips Industry, 2012-2018. The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Biochips Industry.

Global biochips market is forecasted to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union. Among the major industry segments, biochips instruments are expected to exert the highest support to the industry with a CAGR of 20% globally. Microarrays segment accounts for nearly 70% of the industry value while services indicate lesser than 15% of the market value. North America is expected to maintain the highest market share for the biochips industry by 2018; Asian economies are expected to post a large CAGR of 19 percent during 2012-2018. Higher growth rate favors improved industry investments in Asia-Pacific region in comparison with North America and Europe, going ahead.

The report ‘Analysis of Global Biochips Industry, 2012-2018' reviews the latest biochips market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the biochips industry.

Drug Discovery and Development
Diagnostics and Treatment
Research
Forensic
Other (Agriculture, Environmental Sensors, Food Inspection)

The period considered for the biochips market analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Asia-Pacific (Japan, China, India, South Korea, Australia and Rest of Asia-Pacific), Europe (Germany, France, United Kingdom, Italy, Spain, Russia and Rest of Europe), and Rest of the World. The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 640 leading market players are identified and 48 key companies that project improved market activities in the near future are profiled. The report consists of 165 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

The evolution of biochips has opened new vistas in the biological systems. In addition, all other sciences are integrated which cumulatively contribute for a big future of biochip industry. The broad ‘life science' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. Accelerating growth rate exhibited by the biochips industry, even during the recession years, confirms the positive growth prospects going ahead. The field of drug discovery and development research gets more glamorous with the diagnostics and treatment at cellular level. DNA biochips and lab-on-chips have created revolution enabling the target validation. Genome scan is very soon going to become an ultimate weapon for diagnosis. In no time all the information related to genes will be sequenced, annotated and completed along with the list of diseases which are susceptible.

BRICSS cardiac prosthetic devices market forecasts to reach at US$0.45 billion by 2015 at a CAGR of 10.4% during the analysis period 2009-2015. China accounts for nearly 25% of the global value and India claims less than 20% of the market. In terms of CAGR, China is the fastest growing region while South Korea and Brazil are just behind. Among the product types, mechanical heart valves account more nearly half of the market value while tissue and transcatheter segments add up to the remaining half. According to the CAGR growth forecasts, tissue heart valves and transcatheter segment indicate double digit values, indicative of an improved investment returns in the upcoming years.